questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact on patient outcomes of the availability of Enhertu on the NHS.
answerText: Ministers met with the manufacturers of Enhertu, AstraZeneca, and Daiichi Sankyo, in November 2024 to encourage them to engage constructively with NHS England and the National Institute for Health and Care Excellence (NICE) to reach a commercial agreement...
heading: Trastuzumab Deruxtecan